Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy

Lifespan Normative Data on Rates of Brain Volume Changes

(2019) M. Battaglini et al.   NEUROBIOLOGY OF AGING

Contribution of normal aging to brain atrophy in MS

(2019) Christina J. Azevedo et al.   Neurology-Neuroimmunology & Neuroinflammation

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

(2018) Ludwig Kappos et al.   LANCET

Effective treatment of progressive MS remains elusive

(2018) Luanne M Metz et al.   LANCET

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

(2018) Raju Kapoor et al.   LANCET NEUROLOGY

OCT is an alternative to MRI for monitoring MS – YES

(2018) Elias S Sotirchos et al.   Multiple Sclerosis Journal

Multiple Sclerosis

(2018) Daniel S. Reich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impacts of age and sex on retinal layer thicknesses measured by spectral domain optical coherence tomography with Spectralis

(2018) María Nieves-Moreno et al.   PLoS One

OCT is an alternative to MRI for monitoring MS – YES

(2018) Elias S Sotirchos et al.   Multiple Sclerosis Journal

Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis

(2018) Frederike C. Oertel et al.   Expert Review of Neurotherapeutics

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis

(2017) Axel Petzold et al.   LANCET NEUROLOGY

Disease-modifying therapies modulate retinal atrophy in multiple sclerosis

(2017) Julia Button et al.   NEUROLOGY

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

(2017) Xavier Montalban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis

(2016) Benjamin Knier et al.   BRAIN

Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study

(2016) Lisanne J. Balk et al.   JOURNAL OF NEUROLOGY

The APOSTEL recommendations for reporting quantitative optical coherence tomography studies

(2016) Andrés Cruz-Herranz et al.   NEUROLOGY

Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study

(2015) Shiv Saidha et al.   ANNALS OF NEUROLOGY

Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives

(2015) Daniel Ontaneda et al.   LANCET NEUROLOGY

Pathological mechanisms in progressive multiple sclerosis

(2015) Don H Mahad et al.   LANCET NEUROLOGY

Outer retinal changes following acute optic neuritis

(2015) Omar A Al-Louzi et al.   Multiple Sclerosis Journal

Outer retinal changes following acute optic neuritis

(2015) Omar A Al-Louzi et al.   Multiple Sclerosis Journal

Clinical Relevance of Brain Volume Measures in Multiple Sclerosis

(2014) Nicola De Stefano et al.   CNS DRUGS

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

(2014) S Schippling et al.   Multiple Sclerosis Journal

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Retinal layer segmentation of macular OCT images using boundary classification

(2013) Andrew Lang et al.   Biomedical Optics Express

Microcystic macular oedema in multiple sclerosis is associated with disease severity

(2012) J. M. Gelfand et al.   BRAIN

Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study

(2012) Shiv Saidha et al.   LANCET NEUROLOGY

Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography

(2012) P Albrecht et al.   Multiple Sclerosis Journal

Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning

(2012) J. N. Ratchford et al.   NEUROLOGY

Retinal Nerve Fiber Layer Imaging with Spectral-Domain Optical Coherence Tomography

(2012) Christopher K.S. Leung et al.   OPHTHALMOLOGY

The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment

(2012) Prejaas Tewarie et al.   PLoS One

Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes

(2012) Jeffrey M. Gelfand et al.   PLoS One

Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography

(2011) Shiv Saidha et al.   BRAIN

Advances in Analysis of Longitudinal Data

(2010) Robert D. Gibbons et al.   Annual Review of Clinical Psychology

Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration

(2010) A. J. Green et al.   BRAIN

Reproducibility of high-resolution optical coherence tomography in multiple sclerosis

(2010) Stephanie B Syc et al.   Multiple Sclerosis Journal

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY

One-Year Brain Atrophy Evident in Healthy Aging

(2009) A. M. Fjell et al.   JOURNAL OF NEUROSCIENCE

Model Choice Can Obscure Results in Longitudinal Studies

(2009) C. H. Morrell et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

(2009) Bruce D Trapp et al.   LANCET NEUROLOGY